SK Chemicals : Future Business or Management Plans (Fair Disclosure)

Future Business or Management Plans (Fair Disclosure)

※ The following is a future plan, which may be subject to change.
1. Title of business plan	Mid-to-Long-Term Strategy for SK Chemicals' Sustainable Management
2. Details of plan and activity schedule	Purpose	To share the Company's plans for new business in response to the changes in the management environment, and the mid-to-long-term growth strategy for sustainable management
Details of plan	□ SK Chemicals' mid-to-long-term financial goals and investment plan (as of 2025; Separate) - Sales goal : KRW 4 trillion 1) Green materials, etc.: KRW 1.8 trillion 2) Pharmaceutical/Bio: KRW 1 trillion 3) New Portfolio: KRW 1 trillion or more - Investment plan: KRW 1.8 trillion or more 1) Green materials: KRW 1.2 trillion or more 2) Pharmaceutical/Bio: KRW 0.6 trillion or more □ SK Chemicals' mid-to-long-term growth strategy and financial story - Green Chemicals Biz.: Leading company for green materials 1) Goal for conversion to copolyester recycling : 50% recycled copolyester production by 2025 (of the total production target of 300,000 tons) : 100% recycled copolyester production by 2030 (of the total production target of 450,000 tons) 2) Expansion of promising future bio and green materials businesses : Development of new BIO materials such as PO3G and highly flexible PLA 3) Promotion of "Net Zero" via the use of green energy : Promotion of carbon reduction through value creation via conversion to LNG fuel, and the building of a hydrogen economy in the future - Life Science Biz.: Comprehensive bio-life science company 1) New drug development via open innovation : Reduction of development cost/time and uncertainty 2) Construction of a new drug discovery platform using AI : Minimization of failure costs, expansion of new pipelines, and securing of analytical capabilities similar to those of existing AI companies 3) Venture investment and introduction of external tasks : Investments in promising ventures and securing of pipelines, exploration of new business areas, development of the pipelines for introduction, and achievement of investment returns 4) Entry into new bio field : Gene editing/gene therapy, target protein degradation, cell therapy, etc.
Proposed schedule	Start date	-
End date	-
Expected investment amount (KRW)	KRW 1.8 trillion in total (by 2025)
Expected results	Enhanced corporate and shareholder values through the establishment of strategies for profitability improvement, reduced volatility, and sustainable growth under the mid- to long-term management goals
3. Potential difficulties in implementation	-
4. Date of board resolution (decision date)	-
5. Details of information released	Information providers	IR Office, SK Chemicals Co.,Ltd.
Information recipients	Domestic and foreign institutional investors, analysts, normal investors, mass media organizations, etc.
Date & time of information released	Mar 28, 2022, 9:00 AM
Title and place of event held	The 5th General Meeting of Shareholders (G.rium Hall, B2F, SK Chemicals B/D,Postings on SK Chemicals' website, Press release distribution
6. Contact points (Dept. name/tel.)	IR Office / 02-2008-2766
7. Other matters to be factored into investment decisions
- "2. Details of plan and activity schedule" and the reference materials scheduled for posting on the corporate website are SK Chemicals' new business implementation plan and mid-to-long-term management strategies. The relevant materials are provided to help enhance the investors' understanding and include the information on the Company's forecasts, plans, and goals for the future; and the forecast information may change according to changes in the management environment such as future market conditions, as well as the detailed implementation process of the specific tasks. - The relevant materials will be posted on the IR library of SK Chemical's website (https://www.skchemicals.com/ir/public_list.aspx).
Expected disclosure date of progress	-
※ Related disclosure	-